Immunologic adjuvant

Immunologic adjuvant

  • CN 1,909,925 B
  • Filed: 01/19/2005
  • Issued: 10/13/2010
  • Est. Priority Date: 02/20/2004
  • Status: Active Grant
First Claim
Patent Images

1. the immunological adjuvant of a protein vaccine is levamisole or levamisole derivant and pair compositions of octadecyl dimethyl ammonium bromide composition;

  • Described levamisole derivant is levamisole hydrochloride or leoamisole phosphate;

    Wherein, described protein vaccine is a cattle foot and mouth disease O type inactivated vaccine;

    The mass ratio of the described pair of octadecyl dimethyl ammonium bromide and levamisole or levamisole derivant is 1;


View all claims

    Thank you for your feedback